Biocon Pharma receives NMPA approval for Tacrolimus capsules in China
Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval from the National Medical Products Administration (NMPA) in China for Tacrolimus capsules in 0.5mg, 1mg, and 5mg strengths. Tacrolimus, an immunosuppressant, is used …